Status:
NOT_YET_RECRUITING
Effect of a Mobile Health App on Pain and Quality of Life in Patients With Neuropathic Pain in Multiple Sclerosis
Lead Sponsor:
Meryem Kocaslan Toran
Collaborating Sponsors:
Uskudar University
The Scientific and Technological Research Council of Turkey
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system, leading to inflammation, neurodegeneration, and a range of physical and invisible symptoms. Among these, n...
Detailed Description
This randomized controlled trial aims to evaluate the efficacy of a self-management-based mobile health application designed for individuals with Multiple Sclerosis (MS) who experience neuropathic pai...
Eligibility Criteria
Inclusion
- Being 18 years of age or older,
- Having a definitive diagnosis of MS according to the McDonald 2017 criteria,
- Owning a smartphone with an Android operating system,
- Having an Expanded Disability Status Scale (EDSS) score ≤ 5\*,
- Being able to communicate in Turkish,
- Being literate,
- No neurological symptoms that could impair smartphone use (e.g., tremor),
- Pain Detect Pain Questionnaire score of 19 or higher,
- Neuropathic Pain Questionnaire score of 4 or higher,
- Beck Depression Scale score below 17, \*EDSS scores determined by a physician's evaluation will be considered.
Exclusion
- Having undergone surgical interventions on the musculoskeletal system (for at least six months),
- Having a known neurological disorder (epilepsy, dementia)\*,
- Having vision or hearing problems that could affect test performance\*,
- Chronic pain not attributable to neuropathic causes (cancer, carpal tunnel syndrome, postherpetic neuralgia)\*,
- Peripheral vascular complications due to diabetes or other etiologies\*,
- Participation in supervised exercise, home exercise, group exercise, etc., as part of physical therapy\*,
- Participation in psychological therapies (cognitive and/or behavioral therapy, biofeedback), \*
- Participation in mind-body practices (yoga, tai chi, etc.),\*
- Participation in acupuncture, \*
- Receiving invasive treatments (e.g., injections, nerve blocks, spinal cord stimulators, parenteral medications, etc.) \*, \* Patient self-report and medical records will be used as the basis for inclusion; patients with observed vision or hearing impairments during testing will be excluded from the study.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06982742
Start Date
July 1 2025
End Date
December 15 2025
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uskudar University, Faculty of Health Sciences
Istanbul, Turkey (Türkiye)